- Home
- SNSE
as of 12-16-2025 4:00pm EST
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | ROCKVILLE |
| Market Cap: | 10.3M | IPO Year: | 2021 |
| Target Price: | $72.50 | AVG Volume (30 days): | 84.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -19.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.00 - $18.35 | Next Earning Date: | 11-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered SNSE Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Sensei Biotherapeutics Inc. (SNSE)
10% Owner
Avg Cost/Share
$8.13
Shares
6,612
Total Value
$54,574.77
Owned After
158,254
10% Owner, Other
Avg Cost/Share
$7.97
Shares
3,507
Total Value
$27,902.82
Owned After
155,142
10% Owner, Other
Avg Cost/Share
$8.59
Shares
3,105
Total Value
$26,671.95
Owned After
155,142
SEC Form 4
10% Owner
Avg Cost/Share
$12.28
Shares
16,295
Total Value
$187,389.97
Owned After
158,254
10% Owner, Other
Avg Cost/Share
$12.28
Shares
16,295
Total Value
$187,389.97
Owned After
155,142
10% Owner
Avg Cost/Share
$9.06
Shares
5,000
Total Value
$45,300.00
Owned After
158,254
SEC Form 4
10% Owner, Other
Avg Cost/Share
$9.06
Shares
5,000
Total Value
$45,300.00
Owned After
155,142
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc | SNSE | 10% Owner | Dec 9, 2025 | Sell | $8.13 | 6,612 | $54,574.77 | 158,254 | |
| Peyer James | SNSE | 10% Owner, Other | Dec 9, 2025 | Sell | $7.97 | 3,507 | $27,902.82 | 155,142 | |
| Peyer James | SNSE | 10% Owner, Other | Dec 8, 2025 | Sell | $8.59 | 3,105 | $26,671.95 | 155,142 | |
| Cambrian BioPharma Inc | SNSE | 10% Owner | Dec 5, 2025 | Sell | $12.28 | 16,295 | $187,389.97 | 158,254 | |
| Peyer James | SNSE | 10% Owner, Other | Dec 5, 2025 | Sell | $12.28 | 16,295 | $187,389.97 | 155,142 | |
| Cambrian BioPharma Inc | SNSE | 10% Owner | Dec 4, 2025 | Sell | $9.06 | 5,000 | $45,300.00 | 158,254 | |
| Peyer James | SNSE | 10% Owner, Other | Dec 4, 2025 | Sell | $9.06 | 5,000 | $45,300.00 | 155,142 |
Compare SNSE vs Leading Stocks
See how SNSE stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SNSE Sensei Biotherapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.